EP4727581A2 - Pharmazeutische zusammensetzungen zur gezielten freisetzung bioaktiver wirkstoffe mit verbesserter bioverfügbarkeit und verfahren zur verwendung - Google Patents

Pharmazeutische zusammensetzungen zur gezielten freisetzung bioaktiver wirkstoffe mit verbesserter bioverfügbarkeit und verfahren zur verwendung

Info

Publication number
EP4727581A2
EP4727581A2 EP24824277.8A EP24824277A EP4727581A2 EP 4727581 A2 EP4727581 A2 EP 4727581A2 EP 24824277 A EP24824277 A EP 24824277A EP 4727581 A2 EP4727581 A2 EP 4727581A2
Authority
EP
European Patent Office
Prior art keywords
pharmaceutical composition
amino acid
composition
subject
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24824277.8A
Other languages
English (en)
French (fr)
Inventor
Scott Shapiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP4727581A2 publication Critical patent/EP4727581A2/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP24824277.8A 2023-06-14 2024-06-14 Pharmazeutische zusammensetzungen zur gezielten freisetzung bioaktiver wirkstoffe mit verbesserter bioverfügbarkeit und verfahren zur verwendung Pending EP4727581A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363508175P 2023-06-14 2023-06-14
PCT/US2024/034128 WO2024259323A2 (en) 2023-06-14 2024-06-14 Pharmaceutical compositions for targeted delivery of bioactive agents with improved bioavailability and methods of use

Publications (1)

Publication Number Publication Date
EP4727581A2 true EP4727581A2 (de) 2026-04-22

Family

ID=93852837

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24824277.8A Pending EP4727581A2 (de) 2023-06-14 2024-06-14 Pharmazeutische zusammensetzungen zur gezielten freisetzung bioaktiver wirkstoffe mit verbesserter bioverfügbarkeit und verfahren zur verwendung

Country Status (3)

Country Link
EP (1) EP4727581A2 (de)
JP (1) JP2026523510A (de)
WO (1) WO2024259323A2 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080233053A1 (en) * 2005-02-07 2008-09-25 Pharmalight Inc. Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
WO2015023649A2 (en) * 2013-08-12 2015-02-19 3M Innovative Properties Company Peptides for enhancing transdermal delivery
US10806790B1 (en) * 2013-11-12 2020-10-20 Scott Shapiro Pain therapy cream with deep tissue delivery system
SG11201907153RA (en) * 2017-02-07 2019-09-27 Lars Erik Peters Topical formulations and methods

Also Published As

Publication number Publication date
WO2024259323A2 (en) 2024-12-19
WO2024259323A3 (en) 2025-01-23
JP2026523510A (ja) 2026-07-14

Similar Documents

Publication Publication Date Title
AU2019201902B2 (en) Dermal delivery
AU2018347514C1 (en) Methods and compositions for topical delivery
AU2021200081A1 (en) Nanoparticle compositions, formulations thereof, and uses therefor
JP6131194B2 (ja) 皮膚科学的症状を処置するためのエンプティナノ粒子組成物およびその使用
JP2021520373A (ja) Ｃｇｒｐを阻害する際に使用するための神経毒素
JP2019535829A (ja) 大型薬剤の経皮送達
JP2025011085A (ja) プラスミノーゲンアクチベーターインヒビター１（ｐｌａｓｍｉｎｏｇｅｎ ａｃｔｉｖａｔｏｒ ｉｎｈｉｂｉｔｏｒ １）（ＰＡＩ－１）阻害剤（ｉｎｈｉｂｉｔｏｒ）およびその使用
CN102791284A (zh) 治疗或预防毛发脱落或促进毛发生长的方法
WO2024259323A2 (en) Pharmaceutical compositions for targeted delivery of bioactive agents with improved bioavailability and methods of use
JP5836968B2 (ja) ＩｇＥ媒介性疾患の処置方法
HK40029417A (en) Dermal delivery
HK40055571A (en) Plasminogen activator inhibitor 1 (pai-1) inhibitors and uses therefor

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251216

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR